“Safety and Tolerability of Tirbanibulin 1% Treatment of Actinic Keratosis on Face and Scalp in Routine Clinical Practice Across the U.S. (PROAK Study)”. 2023. SKIN The Journal of Cutaneous Medicine 7 (6): s263. https://doi.org/10.25251/skin.7.supp.263.